INSTI® HCV (Hepatitis C Virus) Antibody Self-Test Contrived Result Interpretation - Trial NCT06357819
Access comprehensive clinical trial information for NCT06357819 through Pure Global AI's free database. This phase not specified trial is sponsored by bioLytical Laboratories and is currently Completed. The study focuses on Hepatitis C. Target enrollment is 405 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
bioLytical Laboratories
Timeline & Enrollment
N/A
Oct 12, 2023
Dec 17, 2023
Primary Outcome
Successful Interpretation of contrived devices
Summary
The purpose of this Interpretation Assessment was to document if lay people,
 non-professional and inexperienced in self-testing, were able to successfully perform the
 steps to use a Hepatitis C Virus (HCV) Self-Test (HCVST) device, without product
 familiarization [demonstration].
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06357819
Device Trial